TRAIL (TNF-related apoptosis-inducing ligands) /

TRAIL (TNF-related apoptosis-inducing ligands) /

The discovery of TRAIL (TNF Related Apoptosis Inducing Ligand), also referred to as Apo-2, is in an era of intense research because TRAIL induces many cancer cells to undergo programmed cell death (apoptosis), while having no effect on normal cells. This important protein deserves extensive review a...

Full description

Bibliographic Details
Other Authors: Litwack, Gerald
Format: eBook
Language:English
Published: San Diego ; London : Elsevier Academic, ©2004.
Series:Vitamins and hormones ; v. 67.
Subjects:
Vitamins.
Hormones.
Tumor necrosis factor.
Apoptosis.
Ligands (Biochemistry)
MEDICAL > Nutrition.
Electronic books.
Online Access:Full Text via HEAL-Link
Table of Contents:
  • Chapter 1. Specificity of Molecular Recognition Learned from the Crystal Structures of TRAIL and the TRAIL:sDR5 Complex
  • Chapter 2. Crystal Structure of RANK Ligand Involved in Bone Metabolism
  • Chapter 3. Promoter of TRAIL-R2 Gene
  • Chapter 4. Transcriptional Regulation of the TRAIL-R3 Gene
  • Chapter 5. Monoclonal Antibodies Against TRAIL
  • Chapter 6. Modulation of TRAIL Signaling Complex
  • Chapter 7. TRAIL and NF kB Signaling-A Complex Relationship
  • Chapter 8. CARDINAL Roles in Apoptosis and NFkB Activation
  • Chapter 9. TRAIL in the Airways
  • Chapter 10. TRAIL Death Receptors, Bcl-2 Protein Family, and Endoplasmic Reticulum Calcium Pool
  • Chapter 11. FLIP Protein and TRAIL-Induced Apoptosis
  • Chapter 12. Epidermal Growth Factor and TRAIL Interactions in Epithelial-Derived Cells
  • Chapter 13. TRAIL and Ceramide
  • Chapter 14. TRAIL and Viral Infection
  • Chapter 15. Modulation of TRAIL Signaling for Cancer Therapy
  • Chapter 16. Interferon-Gamma and TRAIL in Human Breast Tumor Cells
  • Chapter 17. Retinoids and TRAIL: Two Cooperating Actors to Fight Against Cancer
  • Chapter 18. Potential for TRAIL as a Therapeutic Agent in Ovarian Cancer
  • Chapter 19. TRAIL and Chemotherapeutic Drugs in Cancer Therapy
  • Chapter 20. Additive Effects of TRAIL and Paclitaxel on Cancer Cells: Implications for Advances in Cancer Therapy
  • Chapter 21. Regulation of Sensitivity to TRAIL by the PTEN Tumor Suppressor
  • Chapter 22. TRAIL and Malignant Glioma
  • Chapter 23. Regulation of TRAIL-Induced Apoptosis by Ectopic Expression of Antiapoptotic Factors.

Similar Items